Article
[Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
Mikrobiyoloji bulteni - 1 Jul 2012
Afşar Ilhan, Barış Ibrahim, Sener Aslı Gamze, Köksal Vedat, Demirci Mustafa
Abstract excerpt
Linezolid which is the first member of oxazolidinone class of synthetic antimicrobial agents, was licensed for the treatment of gram-positive coccal infections in Turkey in 2006. In recent years, multidrug-resistant pathogens, especially vancomycin-resistant enterococci (VRE), have emerged rapidly worldwide and linezolid exhibited good clinical efficacy against VRE. However, linezolid-resistant bacteria have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
